Showing results 1 to 3 of 3
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Reduced changes in bone mineral density in Chronic HBV (CHB) Patients receiving Tenofovir Alafenamide (TAF) compared with Tenofovir Disoproxil Fumarate (TDF) Proceeding/Conference:The Liver Meeting® 2016 | 2016 | ||
Reduced changes in bone mineral density in chronic hepatitis B patients receiving TAF compared with TDF Proceeding/Conference:Conference of the Asian Pacific Association for the Study of the Liver, APASL 2017 | 2017 | ||
RETRACTION: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection Journal:Clinical Gastroenterology and Hepatology | 2018 |